Donald E. Bobo Jr - Dec 12, 2022 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
CVP,Strategy/Corp Development
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Dec 12, 2022
Transactions value $
-$263,104
Form type
4
Date filed
12/12/2022, 05:30 PM
Previous filing
Nov 8, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $237K +6.73K +10.75% $35.20 69.3K Dec 12, 2022 Direct F1
transaction EW Common Stock Sale -$500K -6.73K -9.71% $74.32 62.6K Dec 12, 2022 Direct F1
holding EW Common Stock 38.3K Dec 12, 2022 401(k)
holding EW Common Stock 117K Dec 12, 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Employee Stock Option (Right to Acquire) Options Exercise $0 -6.73K -20% $0.00 26.9K Dec 12, 2022 Common Stock 6.73K $35.20 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 25, 2022.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.